Institute of Medicine advisory: IOM's 35th annual meeting explores pharmaceuticals

October 20, 2005

The Institute of Medicine of the National Academies will hold its 35th annual meeting on Monday, Oct. 24. It will host a daylong public symposium to explore issues related to pharmaceuticals in the 21st century. Topics include drug safety in the United States and the developing world, how consumer drugs are priced and promoted, and the government's role in drug development.

The Institute will also announce its newly elected members and foreign associates. Election results will be available at 10 a.m. EDT on the Web at http://national-academies.org. Reporters can register to receive an embargoed list of new members in advance.

The 2005 winners of the Rhoda and Bernard Sarnat International Prize in Mental Health and the Gustav O. Lienhard Award will be announced as well.

DETAILS:
Oct. 24 from 9 a.m. to 5 p.m. in the auditorium of the National Academies building, 2100 C St., N.W., Washington, D.C. Those who cannot attend may listen to a live audio webcast of the meeting at http://national-academies.org. A full agenda is available online at http://www.iom.edu/event.asp?id=28870.

REPORTERS: To register to attend the meeting or receive the embargoed new members press release, contact the National Academies' Office of News and Public Information; tel. 202-334-2138 or e-mail news@nas.edu.
-end-


National Academies of Sciences, Engineering, and Medicine

Related Pharmaceuticals Articles from Brightsurf:

A plot twist in pharmaceuticals: Single nanoparticles could pave the way for medicines on demand
For the first time, a single, twisted nanoparticle has been accurately measured and characterised in a lab, taking scientists one vital step closer to a time when medicines will be produced and blended on a microscopic scale.

New pharmaceuticals: public research combines efficiency with contained costs
Is the basic research that goes into the development of new drugs more efficiently conducted by public-sector scientists, pharmaceutical firms, or independent private laboratories?

New STM technique points way to new and purer pharmaceuticals
A research project led by chemists at the University of Warwick first used ultrahigh resolution scanning tunnelling microscopy to see the exact location of atoms and bonds within a molecule, and then employed these incredibly precise images to determine the interactions that bond molecules to one another.

Study describes cocktail of pharmaceuticals in waters in Bangladesh
An analysis revealed that water samples held a cocktail of pharmaceuticals and other compounds, including antibiotics, antifungals, anticonvulsants, anesthetics, antihypertensive drugs, pesticides, flame retardants and more.

Treating wastewater with ozone could convert pharmaceuticals into toxic compounds
With water scarcity intensifying, wastewater treatment and reuse are gaining popularity.

Study calls for improved sanitation and the environmental management of pharmaceuticals
Failure to ensure the environmental sustainability of growing patient access to medicines in developing economies could increase the risk of adverse environmental impacts, according to new research led by the University of Plymouth.

Chemicals for pharmaceuticals could be made cheaper and greener by new catalysts
High value chemicals used to make pharmaceuticals could be made much cheaper and quicker thanks to a series of new catalysts made by scientists at the University of Warwick in collaboration with GoldenKeys High-Tech Co., Ltd. in China.

Soaking up pharmaceuticals and personal care products from water
Medications excreted in the urine or dumped into the toilet can end up in the water supply, just like lotions or cosmetics that wash off the body and go down the sink or shower drain.

New study finds river wildlife contain cocaine, pharmaceuticals and pesticides
For the first time, researchers at King's College London, in collaboration with the University of Suffolk, have found a diverse array of chemicals, including illicit drugs and pesticides in UK river wildlife.

Metal-free catalyst to convert aldehyde into ketone, a basic structure of pharmaceuticals
We succeeded in synthesizing a ketone, a basic structure of many pharmaceuticals, from an aldehyde and a carboxylic acid using N-heterocyclic carbene catalyst under mild conditions.

Read More: Pharmaceuticals News and Pharmaceuticals Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.